BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
32 results:

  • 1. Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions.
    Rovira-López R; Gallardo F; Salar A; Colomo L; Pujol RM
    Am J Dermatopathol; 2023 Feb; 45(2):81-85. PubMed ID: 36669069
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
    [No Abstract]    [Full Text] [Related]  

  • 3. T cell lymphoma in the setting of Sjögren's syndrome: T cells gone bad? Report of five cases from a single centre cohort.
    Stergiou IE; Papageorgiou A; Chatzis LG; Tzioufas AG; Voulgarelis M; Goules A
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):125-129. PubMed ID: 33025901
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Application Value of Immunohistochemistry and Bone Marrow Morphology Detection in the Diagnosis and Clinical staging of Non-Hodgkin's Lymphoma].
    Hu N; Ding H; Chen L; Zhao HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):449-453. PubMed ID: 29665914
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chronic lymphocytic leukaemia.
    Hallek M; Shanafelt TD; Eichhorst B
    Lancet; 2018 Apr; 391(10129):1524-1537. PubMed ID: 29477250
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Value of CD, MPO, Ki-67 and C-MYC Positive Rate in the Pathological Tissues and C-MYC Gene of Patients with T-LBL/ALL for Predicting Prognosis].
    Wu Y; Tang HY; Ding YY; Pan XQ; Tan CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):110-115. PubMed ID: 29397827
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2017 Sep; 92(9):946-965. PubMed ID: 28782884
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lymphoma of the Cervix: Case Report and Review of the Literature.
    Hilal Z; Hartmann F; Dogan A; Cetin C; Krentel H; Schiermeier S; Schultheis B; Tempfer CB
    Anticancer Res; 2016 Sep; 36(9):4931-40. PubMed ID: 27630351
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia (CLL)-Then and now.
    Rai KR; Jain P
    Am J Hematol; 2016 Mar; 91(3):330-40. PubMed ID: 26690614
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with cd20-positive B cell PTLD: clues from the PTLD-1 trial.
    Trappe RU; Choquet S; Dierickx D; Mollee P; Zaucha JM; Dreyling MH; Dührsen U; Tarella C; Shpilberg O; Sender M; Salles G; Morschhauser F; Jaccard A; Lamy T; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Leithäuser M; Schlattmann P; Anagnostopoulos I; Raphael M; Riess H; Leblond V; Oertel S;
    Am J Transplant; 2015 Apr; 15(4):1091-100. PubMed ID: 25736912
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
    Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
    Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Chronic lymphocytic leukemia].
    Maurer C; Hallek M
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.
    Miles RR; Arnold S; Cairo MS
    Br J Haematol; 2012 Mar; 156(6):730-43. PubMed ID: 22260323
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adverse prognostic features in chronic lymphocytic leukemia.
    Mougalian SS; O'Brien S
    Oncology (Williston Park); 2011 Jul; 25(8):692-6, 699. PubMed ID: 21874830
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A rare pediatric case of a thymic cytotoxic and lymphoblastic T/NK cell lymphoma.
    Gaiser T; Haedicke W; Becker MR
    Int J Clin Exp Pathol; 2010 Mar; 3(4):437-42. PubMed ID: 20490334
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives.
    Jaksić O; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Mar; 34(1):309-13. PubMed ID: 20432765
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation.
    Ali L; Cheney R; Merzianu M
    J Cutan Pathol; 2011 Feb; 38(2):236-40. PubMed ID: 19719832
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinoma.
    Craig PJ; Calonje JE; Harries M; Stefanato CM
    J Cutan Pathol; 2009 Jun; 36(6):706-10. PubMed ID: 19519600
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.